(Bloomberg) -- Russia resisted pressure from its OPEC allies to make deeper production cuts, pushing the cartel’s high-stakes diplomatic gamble to the brink of failure and sending prices plunging.Energy Minister Alexander Novak arrived from Moscow on Friday morning and told fellow ministers that he favored maintaining the group’s supply reduction at current levels until June, when they could again consider deeper cuts, according to a person familiar with the matter.Ministers from the Organization of Petroleum Exporting Countries told Russia on Thursday that if it doesn’t join them in cutting oil output by another 1.5 million barrels a day to offset the impact of the coronavirus, then the cartel could abandon its reductions altogether. Hours later, the group raised pressure on Moscow again, emerging from an informal meeting at the Saudi delegation’s hotel with a proposal to extend the curbs for even longer than initially suggested.Unless Moscow cuts output, “there will be...
Holding steady under $2/share, you might think now the time to buy into FuelCell Energy (NASDAQ:FCEL).Source: Kaca Skokanova/Shutterstock But not so fast! "Green Economy" stocks may be holding their value even in today's volatile market. But in the case of FuelCell Energy, there are too many red flags to consider it an opportunity.Like Plug Power (NASDAQ:PLUG), FuelCell is making progress signing up big companies for its renewable energy technology. As you may know, I've long been skeptical of Plug Power's long term prospects.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIn the case of FCEL stock, I am even more hesitant. FuelCell has even more limited financing options. Shares also trade at a higher enterprise value/sales (EV/Sales) ratio than Plug Power. * 8 Stocks to Buy in March for a Coronavirus Rebound In short, FCEL stock is not the strongest "green wave" stock for your portfolio. Yet, the stock's volatility...
[Editor's note: "5 Biotech Stocks to Buy for a Strong Growth Prognosis" was previously published in December 2019. It has since been updated to include the most relevant information available.]Biotech stocks have to be the ultimate risk and reward equities. No other sector comes close to the return potential of the sector. Just take a look at the gains for the SPDR S&P Biotech ETF (NYSE:XBI). The ETF and sector benchmark has managed to post average annual returns of nearly 19% over the last decade. That's pretty insane and underscores the kind of potential that biotech stocks can have.But they also come with a ton of risk to get that return. They don't call them lotto tickets for anything. Many biotech stocks are just one bad trial away from crashing, burning and causing plenty of heartache for their shareholders.InvestorPlace - Stock Market News, Stock Advice & Trading TipsHowever, there are ways...
Because I liked Roku (NASDAQ:ROKU) when the stock was trading at $150, and I don't expect coronavirus to trigger another Great Recession, (I think the virus' spread will decelerate greatly within a month or two) I'm even more bullish on Roku stock now than I was a couple of weeks ago.Source: AhmadDanialZulhilmi / Shutterstock.com Meanwhile, besides the shares' attractive valuation, I've thought of a few more potential positive catalysts for Roku stock.Excluding its low-margin player revenue, Roku is trading at a little over 11 times its revenue, according to InvestorPlace columnist Vince Martin. Further, the streaming platform's 2020 guidance indicates that its high-margin revenue from advertising and subscription commissions -- the company calls the combined revenue from these two sources "platform revenue" -- will jump more than 60% year-over-year, Martin reported. He added that:InvestorPlace - Stock Market News, Stock Advice & Trading Tips"There are not a lot of stocks in this...